Skin cancer trial starts for DNA delivery technology
This article was originally published in Clinica
Executive Summary
Genetronics Biomedical has begun a US phase I clinical trial to assess the value of its electroporation-based DNA delivery system, MedPulser, in the treatment of malignant melanoma.